• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Jeffrey Lowenkron Discusses the Impacts of Medicare Advantage Expansion on Oncology Care

Video

The expansion of Medicare Advantage benefits patients, but presents challenges in oncology care, said Jeffrey Lowenkron, MD, chief medical officer of The Villages Health.

The expansion of Medicare Advantage benefits patients, but presents challenges in oncology care, said Jeffrey Lowenkron, MD, chief medical officer of The Villages Health.

Transcript:

Is the expansion of Medicare Advantage a plus or a minus for oncology care, in your view?

I think the expansion of Medicare Advantage, it's always a plus for the patient. Because what Medicare Advantage does, as opposed to the fee-for-service world, is it links and aligns patient outcomes with care delivery. As patients do better, the care delivery systems do better, and as patients do worse, the care delivery systems do worse. In the typical fee-for-service model, generally the care delivery system can do really, really well, and the patients may do very, very poorly. They don't have to align. So from the perspective of the patients, it's always a better care model and payment model to be in Medicare Advantage than traditional fee-for-service.

From the oncology perspective specifically, there are going to be some challenges because obviously with the expansiveness of very expensive medications in the oncology world, the difficulty of figuring out how to pay for those, is a real challenge. I can't tell you whether it's going to be better or worse for them over time.

Related Videos
Will Shapiro
Pat Van Burkleo
Jeff Stark, MD, vice president, head of medical immunology, UCB
Robert Groves, MD
Screenshot of Raajit Rampal, MD, PhD
 Laura Ferris, MD, PhD, professor of dermatology, University of Pittsburgh
Dr Padma Sripada, Columbia Internal Medicine
Screenshot of Jennifer Vaughn, MD, in a Zoom video interview
dr amy paller
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.